HIV, also known as
human immune deficiency virus, spreads through sexual contact with an
HIV-infected person. It is the virus that causes AIDS, a condition wherein the
body losses its immunity towards infectious diseases and succumbs to them. The HIV
diagnostics market deals with
all such medical instruments and tests that are utilized to detect whether a
person has contracted HIV/AIDS. HIV is found in blood and other body fluids.
The worldwide market is estimated to expand to about USD 4.5 billion by the end
of 2022.
Access this full report at : http://www.grandviewresearch.com/industry-analysis/hiv-diagnostics-market
Outlook
The vital component
which is responsible for the expansion of the HIV diagnostics market includes
rising requirement for the development of more sensitive point of care tests
for HIV detection. These tests can be simply adopted at the site of patient
care in resource restricted settings. Technological upgradation of tests which
is estimated to bring forth various point of care and novel rapid tests during
the forecast phase is another prime factor, positively impacting the HIV
diagnostics market.
Moreover,
governmental programs and crusades against HIV and worldwide medical attempts
towards reducing illnesses are likely to serve as future prospects for the
market. Huge unmet needs in the Eastern and Middle Eastern regions of the world
also act as future growth opportunities for the HIV diagnostics market. The
worldwide market was anticipated at around USD 2, 173 million in 2014. It is
likely to expand at about 9.5 percent CAGR through the forecast phase.
Read detailed report or request for Sample copy this
research report:
http://www.ni2014.org/research/hiv-diagnostics-market-outlook-trends-and-forecasts-2015-to-2022#ert_pane1-1
http://www.ni2014.org/research/hiv-diagnostics-market-outlook-trends-and-forecasts-2015-to-2022#ert_pane1-1
Rising HIV
population, developments in medical technologies and growing awareness
regarding HIV/AIDS are the other critical factors that push further development
of the HIV diagnostics market. Shortage of medical labs with advanced
facilities and scarcity of skilled medical experts capable of performing
routine tests are the two main factors which prevent the market from developing
further. Augmented need for easily available, fast HIV and effective
diagnostics tests is also expected to propel the sales of the HIV diagnostics
market.
The anticipated
boost in product offerings to the worldwide market is also poised to support
the sales of the market. Laboratory restrictions come in the way of the HIV
diagnostics market. Intensifying promiscuous behavior involving multiple
partners and growing ‘high risk category’ population also amplify the
utilization of HIV diagnostics. This factor also drives further demand for the
market.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Significant Findings
HIV diagnostic tests
involving the detection of antibodies to HIV occupied the biggest share in
2014. This big share can be credited to the high infiltration rates of HIV
tests, such as Elisa, Rapid, Western Blot in theHIV diagnostics market. These
tests are very accurate and sensitive and are utilized for the testing and confirmation
of HIV. CD4 and Viral Load Testing also captured significant shares in 2014.
Rising HIV
diagnostic products are estimated to further the sales of the HIV diagnostics
market.North America held the biggest share in 2014. It leaded the worldwide
market. This was in view of supportive repayment policies for HIV and other
communicable diseases. The Asian Pacific HIV diagnostics market is projected to
augment more rapidlythan the North American region through the forecast phase.
For More Information about site: http://www.ni2014.org/
No comments:
Post a Comment